Commonly prescribed for: Coccidia, Cystoisospora ohioensis, Toxoplasma andNeospora caninum
Species: Dogs and Cats
Therapeutic Class: Anti-protozoal
Ponazuril is a triazinetrione anti-protozoal drug. Other drugs within the triazine group include diclazuril and toltrazuril. Ponazuril is an active metabolite of toltrazuril; the alternate chemical name for ponazuril is toltrazuril sulfone. Ponazuril has broad spectrum activity against coccidia and protozoa. In 2011, the European Committee for Medicinal Products for Veterinary Use approved a combination product of toltrazuril and emodepside for use in the dog to treat mixed parasitic infections of roundworms and coccidia. This product is not available in the United States. In the United States, there is an FDA approved paste form of ponazuril (Marquis) that is used to treat Sarcocystis neurona in horses.
Ponazuril may be used to treat Neospora, Toxoplasma and coccidiosis in dogs and cats. There is relatively little information in the literature regarding its clinical use other than case reports, but interest in the newer anti-coccidial drugs has increased due to the development of parasite resistance.
Ponazuril was found to be efficacious for the treatment of Cystoisospora ohioensis infections in two separate research studies using beagle puppies. No adverse effects due to treatment were noted in either study. In a study performed on mice, ponazuril was found to be efficacious both to prevent and to treat acute and chronic toxoplasmosis.
Safety during pregnancy or lactation has not been studied. In one study performed on stallions there was no effect on spermatogenesis.
Remember to tell your veterinarian about any medications, vitamins, supplements, or herbal therapies that you are giving to your pet.
No information regarding drug interactions was found.
Under research conditions, a 10x overdose of ponazuril repeated for 3 days caused no adverse effect on beagle puppies.
Wedgewood provides medication options that help ensure accurate dosing, especially for hard to medicate pets. Click below for a complete list of Wedgewood’s dosing forms and strengths.
DOSAGE FORM | BENEFITS | STRENGTHS |
---|---|---|
Anhydrous Oral Suspension | Glycerin-based oral solution with a wide variety of flavoring options | 20 mg/ml to 200 mg/ml |
Capsule | Oral medication available in gelatin or veggie capsule options | 30 mg/cap to 875 mg/cap |
Chew Treat | Flavored, medicated oral soft chew treats | 55 mg/chew to 300 mg/chew |
View all Ponazuril options